| dc.creator | Kosmidis M.H., Vlachos G.S., Anastasiou C.A., Yannakoulia M., Dardiotis E., Hadjigeorgiou G., Sakka P., Ntanasi E., Scarmeas N. | en |
| dc.date.accessioned | 2023-01-31T08:44:30Z | |
| dc.date.available | 2023-01-31T08:44:30Z | |
| dc.date.issued | 2018 | |
| dc.identifier | 10.1097/WAD.0000000000000249 | |
| dc.identifier.issn | 08930341 | |
| dc.identifier.uri | http://hdl.handle.net/11615/75164 | |
| dc.description.abstract | Introduction: Study of the epidemiology of dementia to gain insight into putative predisposing and prophylactic factors is the first step toward establishing effective preventive and therapeutic strategies for this ever-growing public health problem. Relevant data in Greece are scattered and outdated. Methods: We investigated dementia prevalence as part of a population-representative epidemiological study [Hellenic Longitudinal Investigation of Aging and Diet (HELIAD)] in 2 Greek regions. Results: Our sample comprised 1792 adults 65 years of age or older, who received a full neurological and neuropsychological evaluation that led to a consensus diagnosis. The overall prevalence of dementia was 5.0%, with 75.3% of the cases attributed to Alzheimer disease. Dementia odds were 15.8% higher for every year of advancing age and 9.4% lower for every additional year of education. Carrying at least 1 APOE-ϵ4 allele doubled the risk of dementia, whereas sex did not exert a statistically significant effect. Conclusions: Our results are consistent with previous research in Southern European countries; dementia prevalence in Greece is in the lower range of what has been reported globally. © 2018 Wolters Kluwer Health, Inc. All rights reserved. | en |
| dc.language.iso | en | en |
| dc.source | Alzheimer Disease and Associated Disorders | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052891369&doi=10.1097%2fWAD.0000000000000249&partnerID=40&md5=261eba217b7035bd94fc93b974e3f8d6 | |
| dc.subject | apolipoprotein E4 | en |
| dc.subject | apolipoprotein E4 | en |
| dc.subject | aged | en |
| dc.subject | aging | en |
| dc.subject | Alzheimer disease | en |
| dc.subject | Article | en |
| dc.subject | controlled study | en |
| dc.subject | dementia | en |
| dc.subject | diet | en |
| dc.subject | educational status | en |
| dc.subject | female | en |
| dc.subject | gene frequency | en |
| dc.subject | Greece | en |
| dc.subject | human | en |
| dc.subject | major clinical study | en |
| dc.subject | male | en |
| dc.subject | neuropsychological test | en |
| dc.subject | prevalence | en |
| dc.subject | priority journal | en |
| dc.subject | very elderly | en |
| dc.subject | aging | en |
| dc.subject | dementia | en |
| dc.subject | genetics | en |
| dc.subject | health survey | en |
| dc.subject | physiology | en |
| dc.subject | procedures | en |
| dc.subject | Aged | en |
| dc.subject | Aging | en |
| dc.subject | Apolipoprotein E4 | en |
| dc.subject | Dementia | en |
| dc.subject | Diet | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Male | en |
| dc.subject | Population Surveillance | en |
| dc.subject | Lippincott Williams and Wilkins | en |
| dc.title | Dementia Prevalence in Greece | en |
| dc.type | journalArticle | en |